↓ Skip to main content

Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma

Overview of attention for article published in Journal of Neuro-Oncology, August 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
12 X users
facebook
1 Facebook page

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
45 Mendeley
Title
Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma
Published in
Journal of Neuro-Oncology, August 2018
DOI 10.1007/s11060-018-2967-5
Pubmed ID
Authors

Jolanda Derks, Pieter Wesseling, Ellen W. S. Carbo, Arjan Hillebrand, Edwin van Dellen, Philip C. de Witt Hamer, Martin Klein, Geert J. Schenk, Jeroen J. G. Geurts, Jaap C. Reijneveld, Linda Douw

Abstract

Diffuse gliomas have local and global effects on neurophysiological brain functioning, which are often seen as 'passive' consequences of the tumor. However, seminal preclinical work has shown a prominent role for neuronal activity in glioma growth: mediated by neuroligin-3 (NLGN3), increased neuronal activity causes faster glioma growth. It is unclear whether the same holds true in patients. Here, we investigate whether lower levels of oscillatory brain activity relate to lower NLGN3 expression and predict longer progression free survival (PFS) in diffuse glioma patients. Twenty-four newly diagnosed patients with diffuse glioma underwent magnetoencephalography and subsequent tumor resection. Oscillatory brain activity was approximated by calculating broadband power (0.5-48 Hz) of the magnetoencephalography. NLGN3 expression in glioma tissue was semi-quantitatively assessed by immunohistochemistry. Peritumor and global oscillatory brain activity was then compared between different levels of NLGN3 expression with Kruskal-Wallis tests. Cox proportional hazards analyses were performed to estimate the predictive value of oscillatory brain activity for PFS. Patients with low expression of NLGN3 had lower levels of global oscillatory brain activity than patients with higher NLGN3 expression (P < 0.001). Moreover, lower peritumor (hazard ratio 2.17, P = 0.008) and global oscillatory brain activity (hazard ratio 2.10, P = 0.008) predicted longer PFS. Lower levels of peritumor and global oscillatory brain activity are related to lower NLGN3 expression and longer PFS, corroborating preclinical research. This study highlights the important interplay between macroscopically measured brain activity and glioma progression, and may lead to new therapeutic interventions in diffuse glioma patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 13%
Student > Master 6 13%
Student > Bachelor 4 9%
Student > Ph. D. Student 4 9%
Student > Postgraduate 4 9%
Other 6 13%
Unknown 15 33%
Readers by discipline Count As %
Medicine and Dentistry 13 29%
Neuroscience 8 18%
Agricultural and Biological Sciences 2 4%
Physics and Astronomy 1 2%
Linguistics 1 2%
Other 2 4%
Unknown 18 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2020.
All research outputs
#4,475,501
of 25,064,526 outputs
Outputs from Journal of Neuro-Oncology
#408
of 3,208 outputs
Outputs of similar age
#79,070
of 336,887 outputs
Outputs of similar age from Journal of Neuro-Oncology
#8
of 67 outputs
Altmetric has tracked 25,064,526 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,208 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,887 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.